VICRYL MONOFILAMENT VIOLET 4IN (10CM) USP 10-0 (M0.2) SINGLE-ARMED CS140-6 - Product Usage: Inten...
FDA Device Recall #Z-0116-2021 — Class II — September 9, 2020
Recall Summary
| Recall Number | Z-0116-2021 |
| Classification | Class II — Moderate risk |
| Date Initiated | September 9, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Ethicon, Inc. |
| Location | Somerville, NJ |
| Product Type | Devices |
| Quantity | 1,032 eaches (OUS only) |
Product Description
VICRYL MONOFILAMENT VIOLET 4IN (10CM) USP 10-0 (M0.2) SINGLE-ARMED CS140-6 - Product Usage: Intended for ophthalmic soft tissue approximation/ligation. Product Code: V960G
Reason for Recall
Product in the foil package for VICRYL V960 may not match the foil label and sales unit carton. The correct VICRYL suture is size 10-0, 4 inches (10 cm) in length, has monofilament construction, and a single needle. The incorrect VICRYL suture is size 6-0, 18 inches (45 cm) in length, has braided construction, and two needles
Distribution Pattern
International distribution including the countries of Australia, Canada, Japan, and New Zealand
Lot / Code Information
Lot/Serial No.: PJ5352 Expiry Date: 07/31/2024 UDI (GTIN): 10705031051324
Other Recalls from Ethicon, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0487-2025 | Class II | MONOCRYL" (poliglecaprone 25) Suture REF Y936H ... | Oct 8, 2024 |
| Z-0319-2025 | Class II | Coated VICRYL Polyglactin 910 Suture VIO 36IN(9... | Sep 25, 2024 |
| Z-2148-2024 | Class II | MONOCRYL (poliglecaprone 25) Suture - Intended ... | May 10, 2024 |
| Z-2144-2024 | Class II | VICRYL (polyglactin 910) Suture - Indicated for... | May 10, 2024 |
| Z-2147-2024 | Class II | PDS Plus Antibacterial (polydioxanone) Suture -... | May 10, 2024 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.